Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment

AM Lewis, S Varghese, H Xu, HR Alexander - Journal of translational …, 2006 - Springer
… Our focus in this review is to summarize the known data on the role of IL-1 in tumor
progression and metastasis and the use of IL-1 inhibition as a novel therapeutic approach in the …

Interleukin-1β and cancer

C Rébé, F Ghiringhelli - Cancers, 2020 - mdpi.com
… IL-1β and mutated-KRAS seems to increase cancer progression and drug resistance. …
in human breast cancer cells, thus contributing to cancer progression [146]. In colon cancer, …

IL‐1 and IL‐1 regulatory pathways in cancer progression and therapy

A Mantovani, I Barajon, C Garlanda - Immunological reviews, 2018 - Wiley Online Library
… .2, 6 IL-1 is a prototypic inflammatory … IL-1 and its regulation play a pivotal role in cancer-related
inflammation. Here, we will review how IL-1 affects various aspects of tumor progression

Interleukin-1 and nuclear factor kappa B signaling promote breast cancer progression and treatment resistance

S Diep, M Maddukuri, S Yamauchi, G Geshow, NA Delk - Cells, 2022 - mdpi.com
… , IL-1, TNFα, and TLR can promote cancer progression through NF-κB or AP-1. In this review…
of IL-1α and IL-1β in breast cancer (BCa) progression and therapeutic resistance, and state …

[HTML][HTML] Interleukin-1 (IL-1) and the inflammasome in cancer

V Pretre, D Papadopoulos, J Regard, M Pelletier… - Cytokine, 2022 - Elsevier
cancer [1], [2] and while exciting preclinical and clinical data have emerged implicating
inflammation in the development and progression of certain cancers, … and types of cancer is still in …

The interleukin-1 family of cytokines and receptors in human breast cancer: implications for tumor progression

AG Pantschenko, I Pushkar… - International …, 2003 - spandidos-publications.com
… of the IL-1 family in the human breast cancer microenvironment and suggest a role for the
IL-1 family in breast cancer progression based on the correlation of IL-1 family members with …

Roles of interleukin-1 receptor antagonist in prostate cancer progression

YC Fan, KD Lee, YC Tsai - Biomedicines, 2020 - mdpi.com
… Background: Inflammation is known to promote tumor formation and progression; however,
we found a natural anti-inflammatory factor, interleukin (IL)-1 receptor antagonist (IL1RN), in …

Interleukin 1β—a potential salivary biomarker for cancer progression?

A Idris, NB Ghazali, D Koh - Biomarkers in cancer, 2015 - journals.sagepub.com
… release of proinflammatory cytokines, such as interleukin (IL)-1β. There is … cancer progression.
This short review proposes the possibility of using IL-1β as a potential cancer progression

Why not treat human cancer with interleukin-1 blockade?

CA Dinarello - Cancer and Metastasis Reviews, 2010 - Springer
… and has resulted in improved survival in colorectal and lung cancer patients and progression-free
survival in breast cancer patients. [73] Inhibition of VEGF receptor signaling by tyrosine …

[HTML][HTML] The interleukin-1 cytokine family members: Role in cancer pathogenesis and potential therapeutic applications in cancer immunotherapy

B Boersma, W Jiskoot, P Lowe, C Bourquin - Cytokine & growth factor …, 2021 - Elsevier
… The interleukin-1 (IL-1) family is one of … in cancer has been well established in the past
decades. This review sets out to give an overview of the role of each IL-1 family member in cancer